Gartland, Martin J.

Top Publications

Top Publications Authored or Co-Authored by "Gartland, Martin J."

• Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

  The Lancet, Volume 393, No. 10167, Year 2019, Citations 249
• Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial

  The Lancet Infectious Diseases, Volume 19, No. 3, Year 2019, Citations 108
• Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study

  The Lancet HIV, Volume 7, No. 11, Year 2020, Citations 52
• Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trial

  PLoS ONE, Volume 13, No. 10, Article e0205368, Year 2018, Citations 32
• Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254

  Clinical Infectious Diseases, Volume 75, No. 5, Year 2022, Citations 19